JUVEL-LOU VELASCO: Open Payments
NPI 1972086528 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,284 in 26 payments from 11 companies in 2025. Trend: 2023 $2,771 · 2024 $875 · 2025 $2,284
Food & beverage: $1,984Travel & lodging: $300
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 11 | $1,042 |
| E.R. Squibb & Sons, L.L.C. | 2 | $215 |
| Alnylam Pharmaceuticals Inc. | 3 | $166 |
| Ancora Heart, Inc. | 1 | $166 |
| Abbott Laboratories | 2 | $157 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Novo Nordisk Inc | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $75 |
| PFIZER INC. | 2 | $56 |
Products named: Barostim Neo System, AccuCinch, CARDIOMEMS, LOKELMA, JARDIANCE, CAMZYOS, AMVUTTRA, ONPATTRO.
Industry payments across MD — which companies pay providers there.
